Latest debt-to-equity ratio
Mineralys Therapeutics Debt-to-equity ratio
Direct answer
Mineralys Therapeutics's debt-to-equity ratio is 17.72%.
The verified market snapshot reports 17.72%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 10, 2026.
Get free Mineralys Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 17.72%
Explore related company data
View Mineralys Therapeutics's market capitalizationView Mineralys Therapeutics's price-to-book ratioView Mineralys Therapeutics's return on equityView Mineralys Therapeutics's dividend yieldView Mineralys Therapeutics's 52-week price rangeView Mineralys Therapeutics's profit marginView all Mineralys Therapeutics key metricsReturn to Mineralys Therapeutics profile